MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease
This study has been terminated.
(The Clinical Development Program for MGCD0103 is being re-evaluated)
Sponsor:
MethylGene Inc.
Information provided by:
MethylGene Inc.
ClinicalTrials.gov Identifier:
NCT00374296
First received: September 7, 2006
Last updated: April 28, 2011
Last verified: May 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |